Net Loss of Lasa Supergenerics reported to Rs 21.12 crore in the quarter ended June 2025 as against net loss of Rs 2.73 crore during the previous quarter ended June 2024. Sales declined 35.12% to Rs 20.01 crore in the quarter ended June 2025 as against Rs 30.84 crore during the previous quarter ended June 2024.
| Particulars | Quarter Ended | ||
| Jun. 2025 | Jun. 2024 | % Var. | |
| Sales | 20.01 | 30.84 | -35 |
| OPM % | -2.50 | 5.84 | - |
| PBDT | -0.40 | 0.93 | PL |
| PBT | -1.97 | -1.86 | -6 |
| NP | -21.12 | -2.73 | -674 |
Powered by Capital Market - Live News